DarioHealth (DRIO) Competitors

Beyond Air (NASDAQ:XAIR) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, community ranking, media sentiment and analyst recommendations.

Which has better earnings & valuation, XAIR or DRIO?

DarioHealth has higher revenue and earnings than Beyond Air. DarioHealth is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$1.78M	10.86	-$60.24M	-$1.82	-0.23
DarioHealth	$19.15M	1.77	-$59.43M	-$1.68	-0.67

Do analysts recommend XAIR or DRIO?

Beyond Air currently has a consensus target price of $3.67, indicating a potential upside of 768.88%. DarioHealth has a consensus target price of $4.00, indicating a potential upside of 253.98%. Given Beyond Air's higher possible upside, research analysts clearly believe Beyond Air is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
DarioHealth	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to XAIR or DRIO?

In the previous week, Beyond Air had 5 more articles in the media than DarioHealth. MarketBeat recorded 7 mentions for Beyond Air and 2 mentions for DarioHealth. Beyond Air's average media sentiment score of 0.81 beat DarioHealth's score of 0.50 indicating that Beyond Air is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, XAIR or DRIO?

Beyond Air has a beta of -0.12, suggesting that its stock price is 112% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500.

Do institutionals and insiders believe in XAIR or DRIO?

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 19.0% of Beyond Air shares are owned by company insiders. Comparatively, 15.7% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community favor XAIR or DRIO?

DarioHealth received 190 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 67.04% of users gave DarioHealth an outperform vote.

Company	Underperform	Outperform
Beyond Air	Outperform Votes 48 69.57%	Underperform Votes 21 30.43%
DarioHealth	Outperform Votes 238 67.04%	Underperform Votes 117 32.96%

Is XAIR or DRIO more profitable?

DarioHealth has a net margin of -265.33% compared to Beyond Air's net margin of -3,272.46%. DarioHealth's return on equity of -74.64% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-3,272.46%	-240.15%	-109.38%
DarioHealth	-265.33%	-74.64%	-43.99%

Summary

Beyond Air and DarioHealth tied by winning 9 of the 18 factors compared between the two stocks.